Detail of > 5451-09-2
- MSDS Download

- CAS Number:
- 5451-09-2
- Name:
Pentanoicacid, 5-amino-4-oxo-, hydrochloride (1:1)
- Superlist Name:
- 5-Aminolevulinic acid hydrochloride
- Formula:
- C5H10ClNO3
- Molecular Structure:

- Synonyms:
- Levulinicacid, 5-amino-, hydrochloride (8CI);Pentanoic acid, 5-amino-4-oxo-,hydrochloride (9CI);5-Amino-4-oxopentanoic acid hydrochloride;Aminolevulinic acid hydrochloride;Levulan Kerastick;Unguentum-M;d-Aminolevulinicacid hydrochloride;5-Aminolevulinicacid hydrochloride;
- Molecular Weight:
- 167.59
- EINECS:
- 226-679-5
- Melting Point:
- 156-158 °C
- Boiling Point:
- 298.4 °C at 760 mmHg
- Flash Point:
- 134.3 °C
- Solubility:
- 50 mg/mL in water
- Appearance:
- white to pale yellow crystals
- Hazard Symbols:
Xi,
Xn- Risk Codes:
- 36/37/38-66-20/21/22
- Safety:
- 26-36/37-37/39-36Details
Related products
- 5451-09-2Pentanoicacid, 5-amino-4-oxo-, hydrochloride (1:1)
- 402587-64-8Pentanoicacid, 3-amino-4-methyl-, hydrochloride (1:1), (3S)-
- 79416-27-6Pentanoic acid,5-amino-4-oxo-, methyl ester, hydrochloride (1:1)
- 219310-09-5Pentanoic acid,3-amino-4-methyl-, hydrochloride (1:1), (3R)-
- 456-14-4Benzenecarboximidamide,4-fluoro-, hydrochloride (1:1)
- 51761-16-12-Naphthalenol,7-amino-, hydrochloride (1:1)
- 935668-00-13-Azetidinol,3-ethyl-, hydrochloride (1:1)
- 202982-63-6Benzenemethanamine,4-chloro-2-fluoro-, hydrochloride (1:1)
Other Products
- Titanium Dioxide Carbon black Glutathione Adenosine Cable pulling lubricant
- 122341-38-2Phenol,3,3',3'',3'''-(7,8-dihydro-21H,23H-porphine-5,10,15,20-tetrayl)tetrakis-
- 103-93-5Propanoic acid,2-methyl-, 4-methylphenyl ester
- 5451-09-2Pentanoicacid, 5-amino-4-oxo-, hydrochloride (1:1)
- 5131-66-82-Propanol, 1-butoxy-
- 501-81-53-Pyridineacetic acid
- 736-83-41,3-Diazaspiro[4.5]decane-2,4-dione,8-methyl-3-[(phenylamino)methyl]-
- 603-33-8Bismuthine, triphenyl-
- 692-50-22-Butyne,1,1,1,4,4,4-hexafluoro-
- 18979-50-5Phenol, 4-propoxy-
- 71195-64-7Pentanedioic acid,1,5-bis(2-methylpropyl) ester
- 2814-77-92-Naphthalenol,1-[2-(2-chloro-4-nitrophenyl)diazenyl]-
- 483-63-62-Butenamide,N-ethyl-N-(2-methylphenyl)-
- 3774-53-6Thiocyanic acid,4-hydroxy-3-methylphenyl ester
- 13569-71-6Rhenium chloride(ReCl4)
- 1406-18-4VitaminE
Refine Suppliers Do you want your product ranking ahead? Know what is 'Top Seller'!
- Supplier Location:
China (Mainland)(28)
United States(3)
Canada(1)
Germany(1)
Hong Kong(1)
India(1)
- Business Type:
- Importer/Exporter(27)Lab/Research institutions(5)Manufacturers(1)
- Certificates:
- ISO(1)Production License(1)
Please post your buying leads,so that our qualified suppliers
will soon contact you!
*Required Fields
Reference
- Effect of delta-aminolevulinic acid on the resting membrane potential of frog sartorius muscle
- Effect of delta-aminolevulinic acid on the resting membrane potential of frog sartorius muscle. Becker, D. M.; Goldstuck, N.; Kramer, S. (Sch. Pathol., Univ. Witwatersrand, Johannesburg, S. Afr.). S. Afr. Med. J., 49(43), 1790-2 (English) 1975. CODEN: SAMJAF. ISSN: 0038-2469. DOCUMENT TYPE: Journal CA Section: 3 (Biochemical Interactions) d-Aminolevulinic acid-HCl [5451-09-2] decreased the resting membrane potential in frog muscle fibers, apparently by altering the membrane permeability to Na+ and K+. The depolarizing effect of the porphyrin precursor was dose dependent and reversible, and probably involved unknown mechanisms in addn. to the inhibition of Na+, K+-dependent ATPase. The possible role of d-aminolevulinic acid in the prodn. of the neurol. manifestations of porphyria are discussed.
- Effects of light fractionation and different fluence rates on photodynamic therapy with 5-aminolaevulinic acid in vivo
- Effects of light fractionation and different fluence rates on photodynamic therapy with 5-aminolaevulinic acid in vivo. Babilas, P.; Schacht, V.; Liebsch, G.; Wolfbeis, O. S.; Landthaler, M.; Szeimies, R.-M.; Abels, C. 5451-09-2 is the cas registry number. This chemical is also mentioned in this article. (Department of Dermatology, University of Regensburg, Regensburg 93042, Germany). British Journal of Cancer, 88(9), 1462-1469 (English) 2003 Nature Publishing Group. CODEN: BJCAAI. ISSN: 0007-0920. DOCUMENT TYPE: Journal CA Section: 8 (Radiation Biochemistry) To improve efficacy of photodynamic therapy (PDT) with i.v. administered 5-aminolaevulinic acid (ALA) fractionating the light dose or reducing the light intensity may be a possibility. Therefore, Syrian Golden hamsters were fitted with dorsal skinfold chambers contg. an a melanotic melanoma (n=26). PDT was performed (100 mW cm-2, 100 J cm-2, continuously or fractionated, and 25 mW cm-2, 100 J cm-2; continuously or fractionated) using an incoherent light source following i.v. application of ALA. Following fractionated irradn., the light was paused after 20 J cm-2 for 15 min. Prior to and up to 24 h after PDT tissue, pO2 was measured using luminescence lifetime imaging. The efficacy was evaluated by measuring the tumor vol. of a melanotic melanoma cells grown s.c. in the back of Syrian Golden hamsters (n=36). Only high-dose PDT resulted in a significant decrease of pO2. Irresp. of the mode of irradn. only high-dose PDT induced complete remission of all tumors (13 out of 13). It could be shown that low-dose PDT failed to induce a significant decrease of pO2. No significant effect of fractionated irradn. was shown regarding the therapeutic efficacy 28 days after PDT. Thus performing a fractionated PDT with ALA or reducing the light intensity seems not to be successful in clin. PDT according to the present data. .
- About us
- |
- Payment
- |
- Contact us
- |
- Links
- |
- Help Center
- |
- Disclaimer
- |
- Add to favorite
- | SiteMap
- |
- Product SiteMap
- |
- Manufacturers
- |
- Suppliers
©2008 LookChem.com,License:ICP NO.:Zhejiang10014259
[Hangzhou]86-571-85317600,85317603,85317620

